The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanisms
Abstract
Destruction of existing tumor blood vessels may be achieved by targeting vascular endothelial growth factor (VEGF) signaling, which mediates not only endothelial cell proliferation but also endothelial cell survival. In this study, however, intravital microscopy failed to demonstrate that targeting of VEGFR‐2 (by the tyrosine kinase inhibitor SU5416) induces significant regression of experimental tumor blood vessels. Immunohistochemistry, electron microscopy, expression analyses, and in situ hybridization provide evidence that this resistance of tumor blood vessels to VEGFR‐2 targeting is conferred by pericytes that stabilize blood vessels and provide endothelial cell survival signals via the Ang‐1/Tie2 pathway. In contrast, targeting VEGFR‐2 plus the plate‐let‐derived growth factor receptor (PDGFR)‐β system (PDGFR‐β signaling (by SU6668) rapidly forced 40% of tumor blood vessels into regression, rendering these tumors hypoxic as shown by phosphorescence quenching. TUNEL staining, electron microscopy, and apoptosis blocking experiments suggest that VEGFR‐2 plus PDGFR‐β targeting enforced tumor blood vessel regression by inducing endothelial cell apoptosis. We further show that this is achieved by an interference with pericyte‐endothelial cell interaction. This study provides novel insights into the mechanisms of how 1 ) pericytes may provide escape strategies to anti‐angiogenic therapies and 2 ) novel concepts that target not only endothelial cells but also pericyte‐associated pathways involved in vascular stabilization and maturation exert potent anti‐vascular effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., & Ferrara, N. (1993) · Nature · doi:10.1038/362841a0 · Cited by 3,605
Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis
Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N., & Yancopoulos, G. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81813-9 · Cited by 2,847
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Gerber, H.-P., McMurtrey, A., Kowalski, J., Yan, M., Keyt, B. A., Dixit, V., & Ferrara, N. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.46.30336 · Cited by 1,981
Genes Expressed in Human Tumor Endothelium
Croix, B. S., Rago, C., Velculescu, V., Traverso, G., Romans, K. E., Montgomery, E., Lal, A., Riggins, G. J., Lengauer, C., Vogelstein, B., et al. (2000) · Science · doi:10.1126/science.289.5482.1197 · Cited by 1,845
Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., & Qin, Y. (1995) · Nature · doi:10.1038/376070a0 · Cited by 1,820
Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., & Keshet, E. (1995) · Nature Medicine · doi:10.1038/nm1095-1024 · Cited by 1,604
Bergers, G., Song, S., Meyer-Morse, N., Bergsland, E., & Hanahan, D. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17929 · Cited by 1,370
Benjamin, L. E., Hemo, I., & Keshet, E. (1998) · Development · doi:10.1242/dev.125.9.1591 · Cited by 1,265
Benjamin, L. E., Golijanin, D., Itin, A., Pode, D., & Keshet, E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5028 · Cited by 1,241
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
Millauer, B., Shawver, L. K., Plate, K. H., Risaui, W., & Ullrich, A. (1994) · Nature · doi:10.1038/367576a0 · Cited by 1,221
Self-citationFong, T. A. T., Shawver, L. K., Sun, L., Tang, C., App, H., Powell, T., Kim, Y. H., Schreck, R., Wang, X., Risau, W., et al. (1999) · PubMed · Cited by 1,109
Self-citationLack of Pericytes Leads to Endothelial Hyperplasia and Abnormal Vascular Morphogenesis
Hellström, M., Gerhardt, H., Kalén, M., Li, X., Eriksson, U., Wolburg, H., & Betsholtz, C. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.3.543 · Cited by 1,100
Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B. K., Hubbard, S. R., & Schlessinger, J. (1997) · Science · doi:10.1126/science.276.5314.955 · Cited by 1,097
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 983
Gordon, M. S., Margolin, K., Talpaz, M., Sledge, G. W., Holmgren, E., Benjamin, R., Stalter, S., Shak, S., & Adelman, D. C. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.3.843 · Cited by 913
Hirschi, K. K., Rohovsky, S. A., & D'Amore, P. A. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.141.3.805 · Cited by 796
Specialization of tumour vasculature
Ruoslahti, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc724 · Cited by 722
Prewett, M. C., Huber, J., Li, Y., Santiago, A., O'Connor, W., King, K. D., Overholser, J. C., Hooper, A. T., Pytowski, B., Witte, L., et al. (1999) · PubMed · Cited by 713
Kim, I., Kim, H. G., So, J.-N., Kim, J. H., Kwak, H. J., & Koh, G. Y. (2000) · Circulation Research · doi:10.1161/01.res.86.1.24 · Cited by 649
Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation
Daemen, M. A. R. C., van ‘t Veer, C., Denecker, G., Heemskerk, V. H., Wolfs, T. G. A. M., Clauss, M., Vandenabeele, P., & Buurman, W. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6974 · Cited by 566
Carroll, M., Ohno-Jones, S., Tamura, S., Buchdunger, E., Zimmermann, J., Lydon, N. B., Gilliland, D. G., & Druker, B. J. (1997) · Blood · doi:10.1182/blood.v90.12.4947 · Cited by 554
Benjamin, L. E., & Keshet, E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8761 · Cited by 506
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
Laird, A., Vajkoczy, P., Shawver, L. K., Thurnher, A., Liang, C., Mohammadi, M., Schlessinger, J., Ullrich, A., Hubbard, S. R., Blake, R. A., et al. (2000) · PubMed · Cited by 494
Self-citationPericyte involvement in capillary sprouting during angiogenesis in situ
Nehls, V., Denzer, K., & Drenckhahn, D. (1992) · Cell and Tissue Research · doi:10.1007/bf00645048 · Cited by 376
Blood vessel maturation: vascular development comes of age
Darland, D. C., & D’Amore, P. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6127 · Cited by 335
Drevs, J., Hofmann, I., Hugenschmidt, H., Wittig, C., Madjar, H., Müller, M., Wood, J. M., Martiny‐Baron, G., Unger, C., & Marmé, D. (2000) · PubMed · Cited by 308
Phase I Study of Recombinant Human Endostatin in Patients With Advanced Solid Tumors
Herbst, R. S., Hess, K. R., Tran, H. T., Tseng, J. E., Mullani, N. A., Charnsangavej, C., Madden, T., Davis, D. W., McConkey, D. J., O’Reilly, M. S., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.11.061 · Cited by 274
Jayson, G. C., Zweit, J., Jackson, A., Mulatero, C., Julyan, P., Ranson, M., Broughton, L., Wagstaff, J., Hakannson, L., Groenewegen, G., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1484 · Cited by 258
Sundberg, C., Kowanetz, M., Brown, L. F., Detmar, M., & Dvorak, H. F. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780433 · Cited by 253
Kerbel, R. S., Yu, J., Tran, J., Man, S., Viloria-Petit, A., Klement, G., Coomber, B. L., & Rak, J. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1013172910858 · Cited by 237
Schlingemann, R. O., Rietveld, F. J. R., de Waal, R. M. W., Ferrone, S., & Ruiter, D. J. (1990) · Europe PMC (PubMed Central) · Cited by 224
Vajkoczy, P., Farhadi, M. R., Gaumann, A. K. A., Heidenreich, R., Erber, R., Wunder, A., Tonn, J. C., Menger, M. D., & Breier, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14105 · Cited by 219
Self-citationMendel, D. B., Schreck, R., West, D. C., Li, G., Strawn, L. M., Tanciongco, S. S., Vasile, S., Shawver, L. K., & Cherrington, J. M. (2000) · PubMed · Cited by 215
Reinmuth, N., Liu, W., Jung, Y. D., Ahmad, S. A., Shaheen, R. M., Fan, F., Bucana, C. D., McMahon, G., Gallick, G. E., & Ellis, L. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0693fje · Cited by 214
Analysis of Mural Cell Recruitment to Tumor Vessels
Abramsson, A., Berlin, O., Papayan, H., Paulin, D., Shani, M., & Betsholtz, C. (2002) · Circulation · doi:10.1161/hc0102.101437 · Cited by 178
Hawighorst, T., Skobe, M., Streit, M., Hong, Y., Velasco, P., Brown, L. F., Riccardi, L., Lange‐Asschenfeldt, B., & Detmar, M. J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62565-5 · Cited by 173
Vajkoczy, P., Menger, M. D., Vollmar, B., Schilling, L., Schmiedek, P., Hirth, K. P., Ullrich, A., & Fong, T. A. T. (1999) · Neoplasia · doi:10.1038/sj.neo.7900006 · Cited by 161
Self-citationWesseling, P., Schlingemann, R. O., Rietveld, F. J. R., Link, M., Burger, P. C., & Ruiter, D. J. (1995) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199505000-00003 · Cited by 146
Laird, A., Christensen, J. G., Li, G., Carver, J., Smith, K., Xin, X., Moss, K. G., Louie, S. G., Mendel, D. B., & Cherrington, J. M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0700com · Cited by 131
Vajkoczy, P., Schilling, L., Ullrich, A., Schmiedek, P., & Menger, M. D. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199805000-00006 · Cited by 120
Self-citationPark, Y. S., Kim, N. H., & Jo, I. (2003) · Microvascular Research · doi:10.1016/s0026-2862(02)00035-3 · Cited by 109
Intravital Fluorescence Videomicroscopy to Study Tumor Angiogenesis and Microcirculation
Vajkoczy, P., Ullrich, A., & Menger, M. D. (2000) · Neoplasia · doi:10.1038/sj.neo.7900062 · Cited by 101
Self-citationA quantitative study of blood-brain barrier permeability ultrastructure in a new rat glioma model
Stewart, P. A., Hayakawa, K., Hayakawa, E., Farrell, C. L., & Maestro, R. F. D. (1985) · Acta Neuropathologica · doi:10.1007/bf00688129 · Cited by 91
Chekenya, M., Enger, P. Ø., Thorsen, F., Tysnes, B. B., Al‐Sarraj, S., Read, T., Furmanek, T., Mahesparan, R., Levine, J. M., Butt, A. M., et al. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00412.x · Cited by 79
Wanner, G. A., Mica, L., Wanner, E., Kolb, S., Hentze, H., Trentz, O., & Ertel, W. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.10.1239 · Cited by 63
Glioma cell migration is associated with glioma‐induced angiogenesis in vivo
Vajkoczy, P., Goldbrunner, R., Farhadi, M., et al. (1999) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(99)00021-0 · Cited by 45
Self-citationStewart, P. A., Farrell, C. L., & Maestro, R. F. D. (1991) · International Journal of Radiation Biology · doi:10.1080/09553009114551701 · Cited by 27
Cyclooxygenase 2 selective inhibitors in cancer treatment and prevention
Menter, D. G. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.12.1749 · Cited by 10
Cited by
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
Armulik, A., Genové, G., & Betsholtz, C. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.07.001 · Cited by 2,653
“Double targeting of both endothelial cells and pericytes has been suggested to have better antitumoral effect than targeting of any of the cell types alone (Bergers et al., 2003; Erber et al., 2004).”
BackgroundMicroenvironmental regulation of tumour angiogenesis
De Palma, M., Biziato, D., & Petrova, T. V. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.51 · Cited by 1,847
Tumor angiogenesis and vascular normalization: alternative therapeutic targets
Viallard, C., & Larrivée, B. (2017) · Angiogenesis · doi:10.1007/s10456-017-9562-9 · Cited by 1,424
Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
Van Meir, E. G., Hadjipanayis, C. G., Norden, A. D., Shu, H. K., Wen, P. Y., & Olson, J. J. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20069 · Cited by 1,372
Metadata
- Authors
- Erber, R., Thurnher, A., D. Katsen, A., Groth, G., Kerger, H., Hammes, H., D. Menger, M., Ullrich, A., & Vajkoczy, P.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-12-04
- Volume
- 18
- Issue
- 2
- Pages
- 1-25
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2112940666
- Cited by
- 610
- References
- 49
- FWCI
- 7.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.